Lupin Ramps Up Strategy to Counter U.S. Tariff Threat, Posts 52% Profit Surge
Mumbai, August 7, 2025 — Indian pharmaceutical giant Lupin is drawing up a multi-pronged strategy to navigate the looming threat of U.S. tariffs, while celebrating a robust 52% year-on-year surge…
Motilal Oswal Flags 9–11% Pharma Growth in India by FY 26; Recommends Five Stocks
Motilal Oswal Wealth Management projects India’s pharmaceutical sector to grow at 9–11% by fiscal 2026 and has spotlighted five pharma and healthcare stocks—Lupin, Mankind Pharma, Piramal Pharma, IPCA Labs, and…
Lincoln Pharma posts Rs 11.62 cr profit for Jan-Mar; revenue at Rs 161 cr
Lincoln Pharmaceuticals on Thursday reported a net profit of Rs 11.62 crore for the March quarter of 2024-25 and said it is building a portfolio in lifestyle and chronic segments,…
Lupin to boost complex generics in US, EU; eyes chronic growth in India
Lupin, which plans to develop the specialty business, is eyeing higher revenue share from its complex generics portfolios in the US and Europe. Moreover, with a pipeline of over 200…
What is attracting private equity funds to Indian pharma?
Scan any verbiage, online or in print, on Indian pharma and you are unlikely to miss space devoted to some of India’s leading pharma promoters contemplating a stake sale, either…
US FDA Warns Two Drugmakers Including Medgel From India Over DEG, EG Testing Lapses
Maryland : The US Food and Drug Administration (FDA) has reprimanded two drugmakers — Avlon Industries based in Melrose Park, Illinois, and Medgel based in Pithampur, Madhya Pradesh, India — over…
Top Drugmakers Bet On Trade Generics To Grow Beyond Metros
Mumbai : Trade generics is seeing a lot of action in recent times with the entry of large domestic pharmaceutical companies, who want to expand beyond metros and other top…